Choose the health content that’s right for you, and get it delivered right in your inbox.
Recently, Timothy (TJ) Bourdeau, BS, research tech at AdventHealth Digestive Institute Tampa, gave a presentation at the Academic Surgical Congress (ASC) 2020 meeting. TJ’s presentation highlighted a research study lead by liver surgeon, Iswanto Sucandy, MD, that focused on AdventHealth Tampa’s experience in patient outcomes in patients with diabetes following major liver resections. While the surgical robot allows for this operation to be done as a closed procedure, Dr. Sucandy wanted to make sure patients still received the best outcomes from hepatectomies ensuring that diabetes would not make a more complicated postoperative course.
Dr. Sucandy’s team found that Digestive Institute Tampa’s surgical outcomes for patients with diabetes who underwent major hepatectomy were similar to the outcomes of those who do not have diabetes. The study concluded that using the surgical robot for major hepatectomy for patients with diabetes is just as safe as it is for patients without diabetes.
The presentation, titled “Effects of Diabetes on Robotic Major Hepatectomy: A Patient Population to be Abandoned?” was presented at the ASC meeting, held February 4-6 in Orlando.